West-Ward Prednisone Tablets Recall: Underweight Tablets Risk
West-Ward Pharmaceutical recalls 100-count Prednisone tablets (1 mg) due to underweight tablets found in some lots. Consumers should contact the company for details.
Lower-risk recall
Failed Tablet/Capsule Specifications: Discovery of an underweight tablet.
Contact the company
What happened, in plain English
West-Ward Pharmaceutical is recalling 100-count Prednisone tablets (1 mg) because some tablets were found to be underweight. This could affect the medication's effectiveness, but the recall does not indicate a safety risk that requires immediate action. Read more at govinfonow.com/recall/42302-west-ward-prednisone-tablets-recall-underweight-tablets-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/42302-west-ward-prednisone-tablets-recall-underweight-tablets-risk · Updated October 9, 2026 · FDA enforcement record: FDA #D-0008-2017
Cite this page
“West-Ward Prednisone Tablets Recall: Underweight Tablets Risk.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/42302-west-ward-prednisone-tablets-recall-underweight-tablets-risk. Based on FDA recall #D-0008-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0008-2017%22&limit=1).
Why it’s dangerous
The tablets were found to be underweight during quality checks. This could mean the medication dose is less than intended, potentially reducing effectiveness. However, the recall does not indicate a risk of injury or serious health issues.
Who’s affected
People who have the 100-count Prednisone tablets (1 mg) from West-Ward Pharmaceutical, distributed by West-Ward Pharmaceuticals Corp. in Eatontown, NJ, are affected. Those using prescription steroids for conditions like arthritis or autoimmune diseases are most at risk.
How to tell if you have this one
Check for the 100-count Prednisone tablets (1 mg) with NDC code 0054-4741-25. The lot number 660621A was produced and expires January 31, 2018.
- Brand
West-Ward Pharmaceutical- Category
Drug
What to do — step by step
Check Product Details
Look for the NDC code 0054-4741-25 and lot number 660621A on the product label.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “US Nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 14 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0008-2017 (October 3, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0008-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.